Checking for bladder damage during bladder tumor surgery
Part of Cancer clinical trials.
This study looks at whether a simple check during bladder tumor surgery can help find injuries to the bladder. It may help make surgery safer and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are scheduled to have surgery to remove a bladder tumor.
- The surgery can be a first removal, a second removal, or done to check or stage the tumor.
- complete surgery details are available.
- You are willing and able to give informed consent if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a urine test that may help find bladder cancer early without needing invasive procedures. It is for people with high-grade or high-risk non-muscle-invasive bladder cancer who are receiving or have received BCG treatment.
This study looks at how fluid absorbed during bladder cancer removal surgery affects cell-free DNA (tiny pieces of cancer DNA) in your blood. Researchers want to understand if these blood markers can help predict surgery outcomes and guide treatment decisions.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
This trial checks if doing a urine culture before bladder tumor surgery can help prevent fever from urinary tract infections after surgery. It compares two ways of managing pre-surgery urine testing to see which is more effective in reducing post-surgery infection risks.
This trial tests non-invasive tests (using urine samples and scheduled bladder procedures) to help detect bladder cancer. It may be helpful if you are having bladder evaluation or surgery and your care team wants better ways to detect cancer without invasive testing beyond what you already need.
This study looks at how the bladder reacts to a standard treatment called BCG, which is given after surgery for early-stage bladder cancer. By checking the tissue and urine before treatment, the study aims to understand if the bladder is ready for BCG therapy, which could help improve outcomes.
Hear when a new Bladder (Urothelial, Transitional Cell) Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.